{"id":"https://openalex.org/W244746785","doi":null,"title":"Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.","display_name":"Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients.","alternate_titles":[],"publication_year":2008,"publication_date":"2008-09-01","ids":{"openalex":"https://openalex.org/W244746785","mag":"244746785","pmid":"https://pubmed.ncbi.nlm.nih.gov/19031956"},"language":"en","primary_location":{"id":"pmid:19031956","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19031956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W244746785"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://iris.unito.it/bitstream/2318/131490/1/Ant%20Res%20Bitossi%20et%20al%202008.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073879276","display_name":"Raffaella Bitossi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155833","display_name":"Ospedale San Luigi Gonzaga","ror":"https://ror.org/04nzv4p86","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210155833"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Raffaella Bitossi","raw_affiliation_strings":["Oncologia Medica, Dipartimento di Scienze Cliniche e Biologiche, Universit\u00e0 di Torino, Azienda Ospedaliero Universitaria San Luigi, 10043 Orbassano, Torino, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologia Medica, Dipartimento di Scienze Cliniche e Biologiche, Universit\u00e0 di Torino, Azienda Ospedaliero Universitaria San Luigi, 10043 Orbassano, Torino, Italy","institution_ids":["https://openalex.org/I4210155833","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046689226","display_name":"Carla Maria Sculli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carla Maria Sculli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071938312","display_name":"Marco Tampellini","orcid":"https://orcid.org/0000-0003-0857-5135","observed_orcids":["https://orcid.org/0000-0003-0857-5135"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marco Tampellini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004879039","display_name":"Irene Alabiso","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Irene Alabiso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050466636","display_name":"Maria Pia Brizzi","orcid":"https://orcid.org/0000-0001-9724-2927","observed_orcids":["https://orcid.org/0000-0001-9724-2927"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Pia Brizzi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017298616","display_name":"Annamaria Ferrero","orcid":"https://orcid.org/0000-0002-2909-3699","observed_orcids":["https://orcid.org/0000-0002-2909-3699"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Ferrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059152864","display_name":"Azzurra Ottone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Azzurra Ottone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018291130","display_name":"Elisa Bellini","orcid":"https://orcid.org/0000-0003-0957-8354","observed_orcids":["https://orcid.org/0000-0003-0957-8354"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisa Bellini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027971272","display_name":"G. Gorzegno","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gabriella Gorzegno","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050426287","display_name":"Alfredo Berruti","orcid":"https://orcid.org/0000-0002-2952-9560","observed_orcids":["https://orcid.org/0000-0002-2952-9560"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfredo Berruti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077674568","display_name":"Luigi Dogliotti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luigi Dogliotti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0232,"has_fulltext":true,"cited_by_count":18,"citation_normalized_percentile":{"value":0.7677714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"28","issue":"5B","first_page":"3055","last_page":"3060"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.984000027179718},{"id":"https://openalex.org/keywords/third-line-chemotherapy","display_name":"third-line chemotherapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/refractory-colorectal-cancer","display_name":"refractory colorectal cancer","score":0.8949999809265137},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9670000076293945},{"id":"https://openalex.org/keywords/palliative-chemotherapy","display_name":"palliative chemotherapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8793700933456421},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.8728660941123962},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.854254961013794},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8529403209686279},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.7746238708496094},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7057030200958252},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6357031464576721},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.6339625716209412},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.596174418926239},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5942592620849609},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5717703104019165},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.5577206015586853},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5566982626914978},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5158902406692505},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5132336616516113},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4575450122356415},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36886340379714966},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36667144298553467},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32568830251693726},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077146","descriptor_name":"Irinotecan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077150","descriptor_name":"Oxaliplatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002166","descriptor_name":"Camptothecin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"pmid:19031956","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19031956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unito.it:2318/131490","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2318/131490","pdf_url":"https://iris.unito.it/bitstream/2318/131490/1/Ant%20Res%20Bitossi%20et%20al%202008.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unibs.it:11379/469119","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11379/469119","pdf_url":null,"source":{"id":"https://openalex.org/S4306400804","display_name":"Institutional Research Information System (Universit\u00e0 degli Studi di Brescia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I66752286","host_organization_name":"University of Milano-Bicocca","host_organization_lineage":["https://openalex.org/I66752286"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"mag:244746785","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19031956","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:iris.unito.it:2318/131490","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2318/131490","pdf_url":"https://iris.unito.it/bitstream/2318/131490/1/Ant%20Res%20Bitossi%20et%20al%202008.pdf","source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W244746785.pdf","grobid_xml":"https://content.openalex.org/works/W244746785.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W222088725","https://openalex.org/W1973137136","https://openalex.org/W1973438330","https://openalex.org/W2007742741","https://openalex.org/W2029409133","https://openalex.org/W2035864521","https://openalex.org/W2038033632","https://openalex.org/W2039168286","https://openalex.org/W2062300002","https://openalex.org/W2071971507","https://openalex.org/W2081174487","https://openalex.org/W2086883602","https://openalex.org/W2089492563","https://openalex.org/W2099386389","https://openalex.org/W2109332037","https://openalex.org/W2110768299","https://openalex.org/W2124863615","https://openalex.org/W2133399075","https://openalex.org/W2135352785","https://openalex.org/W2139248078","https://openalex.org/W2141817518","https://openalex.org/W2142052493","https://openalex.org/W2155805287","https://openalex.org/W2157416388","https://openalex.org/W2169699992","https://openalex.org/W2170459060","https://openalex.org/W2268185737","https://openalex.org/W2271913383","https://openalex.org/W2411875523","https://openalex.org/W4244082907"],"related_works":["https://openalex.org/W2591346934","https://openalex.org/W1719647987","https://openalex.org/W2243091290","https://openalex.org/W1789531256","https://openalex.org/W2029179822","https://openalex.org/W2248627320","https://openalex.org/W2605213373","https://openalex.org/W2360939304","https://openalex.org/W1981535315","https://openalex.org/W2056167746"],"abstract_inverted_index":{"BACKGROUND:":[0],"There":[1],"is":[2],"no":[3],"standard":[4],"treatment":[5,18],"for":[6,141],"patients":[7,51,107,116,144],"with":[8,40,117,145],"advanced":[9],"colorectal":[10],"cancer":[11],"(CRC)":[12],"progressing":[13,52],"after":[14,53],"irinotecan":[15],"and":[16,19,36,65,79,83,96,127,137],"oxaliplatin":[17],"having":[20],"good":[21],"performance":[22],"status":[23],"(PS).":[24],"PATIENTS":[25],"AND":[26],"METHODS:":[27],"We":[28],"investigated":[29],"gemcitabine":[30,126],"1,000":[31],"mg/m2":[32],"days":[33],"1,":[34],"8":[35],"15":[37],"q28d":[38],"combined":[39],"protracted":[41],"5-fluorouracil":[42,128],"continuous":[43,129],"infusion":[44,130],"at":[45,119],"200":[46],"mg/m2/day,":[47],"in":[48,62,69,105],"37":[49],"consecutive":[50],"oxaliplatin-irinotecan-containing":[54],"chemotherapies.":[55],"RESULTS:":[56],"Partial":[57],"response":[58],"(PR)":[59],"was":[60,103,131],"achieved":[61],"4":[63],"(10.8%)":[64],"disease":[66],"stabilization":[67],"(SD)":[68],"19":[70],"(51.4%)":[71],"cases":[72],"(PR+SD:":[73],"62.2%).":[74],"Median":[75],"time":[76],"to":[77,133],"progression":[78],"survival":[80],"were":[81,90],"4.2":[82],"8.9":[84],"months,":[85],"respectively.":[86],"Grade":[87],"III":[88],"toxicities":[89],"thrombocytopenia,":[91],"neutropenia":[92],"(in":[93,98],"3":[94],"patients)":[95],"mucositis":[97],"2":[99],"patients).":[100],"Clinical":[101],"benefit":[102],"observed":[104],"18":[106],"(48.6%":[108],"of":[109,114,125],"the":[110],"entire":[111],"population;":[112],"64.3%":[113],"those":[115],"PS>0":[118],"study":[120],"entry).":[121],"CONCLUSION:":[122],"The":[123],"combination":[124],"found":[132],"be":[134],"an":[135],"active":[136],"manageable":[138],"palliative":[139],"regimen":[140],"heavily":[142],"pre-treated":[143],"metastatic":[146],"CRC.":[147]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W244746785","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
